Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving ChangeAddison, TX, Jan. 07, 2025 (GLOBE NEWSWIRE) -- PatentVest, a leader in intellectual property (IP) intelligence and strategy, has released its latest report, “Continuous Glucose Monitoring (CGM): An Evolving Innovation Landscape.” This in-depth analysis explores the rapidly growing CGM market, offering valuable insights into the trends, key players, and opportunities that are shaping the future of diabetes care.
MDB Capital Holdings Provides Third Quarter 2024 UpdateManagement to Host Conference Call Today at 4:30 p.m. ET
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel CapabilitiesProject is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern TimeAddison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m. Eastern Time to discuss its results for the third quarter 2024. A press release detailing these results will be issued prior to the call.
Invizyne Technologies Announces Closing of Initial Public OfferingMonrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the closing of its initial public offering of 1,875,000 shares of its common stock at a public offering price of $8.00 per share. The shares began trading on NASDAQ under the ticker symbol “IZTC” on November 13, 2024.
Invizyne’s Nasdaq IPO Marks New Era of BiomanufacturingUnderlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
Invizyne Technologies Begins Trading on NASDAQNext Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Invizyne Technologies Announces Pricing of $15 Million Initial Public OfferingShares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”
MDB Capital Expands Board, Appoints Daniel Torpey as New DirectorAddison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB Capital”), a public venture platform focused on launching category-leading deep technology companies, today announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024.
MDB Capital Holdings Unveils Unified Corporate BrandingAddison, TX, May 22, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announces its self-clearing broker dealer and associated online and mobile trading platforms will now unify under one brand name, MDB Capital.
MDB Capital Holdings Year-End UpdateManagement to Host Zoom Webinar Today at 4:30 p.m. ET
MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern TimeAddison, Texas, April 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, plans to host a Zoom webinar on Wednesday April 17, 2024 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full fiscal year ended December 31, 2023. A press release detailing these results will be issued prior to the call.
5 Tech Stocks to Buy Now, Ahead of the Q1 ReportsTech stocks had a market reset in Q1 2024 and are now in a position to rally higher with analysts' revisions to lead the price action.
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on NasdaqMonrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC, (
NASDAQMDBH) ("MDB") – today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering.
MDB Capital Holdings Issues Annual Letter to ShareholdersAddison, TX, Jan. 31, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today released its annual letter to shareholders from its CEO and Co-Founder, Christopher Marlett.
MDB Capital Holdings Reports Third Quarter 2023 ResultsAddison, TX, Nov. 15, 2023 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (
NASDAQMDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, yesterday reported results for its third quarter ended September 30, 2023 on form 10-Q filed with the Securities and Exchange Commission, and will highlight recent corporate progress on today’s call with management.
